Clinical Trials on Glabellar Crease

Total 10000 results

‹
1
2
...
65
66
67
68
69
70
71
...
199
200
›

National Cancer Institute, Egypt

Recruiting

Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy Surgeries

Breast Cancer

Egypt
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Response-Based Local Therapy for Regionally Advanced Breast Cancer

Breast Cancer

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer (ST-A-TN)

Breast Cancer

China
Clinica Universidad de Navarra, Universidad de...

Not yet recruiting

NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) (OXIGENATE)

Breast Cancer
Hoffmann-La Roche

Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer (optINAVO)

Breast Cancer

Spain, Belgium, United States, United Kingdom, Argentina, Australia, Turkey (Türkiye)
Fudan University

Not yet recruiting

Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)

Breast Cancer
Tianjin Medical University Cancer Institute and...
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status

Breast Cancer

China
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Breast Cancer

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

A Single-arm, Prospective, Multi-center Cohort Study Based on Deep Learning-based cfDNA Fragment Omics to Verify the TuFEst Model for the Staging Diagnosis of Breast Cancer Lesions and Lymph Nodes

Breast Cancer
First Hospital of China Medical University
Liaoning Cancer Hospital & Institute

Not yet recruiting

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

Breast Cancer
Anhui Provincial Cancer Hospital

Not yet recruiting

An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer

Breast Cancer
Memorial Sloan Kettering Cancer Center

Recruiting

Factors Associated With Breast Cancer Risks and Outcomes

Breast Cancer

United States
Elsan

Not yet recruiting

Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer (AELO)

Breast Cancer

France
Zhimin Shao

Not yet recruiting

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC

Breast Cancer
Novartis Pharmaceuticals

Recruiting

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters. (REPOWER)

Breast Cancer

United Kingdom
University of California, San Diego

Recruiting

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. (AIM-BRIGHT)

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
The City College of New York

Recruiting

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer

Breast Cancer

United States
Risen (Suzhou) Pharma Tech Co., Ltd.

Recruiting

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Breast Cancer

China
Anhui Provincial Cancer Hospital

Not yet recruiting

A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients

Breast Cancer
Hospital Costa del Sol

Not yet recruiting

Digital Tool for Psychological Support in Women With Breast Cancer (SerenApp)

Breast Cancer

Spain
Nagoya City University
Novartis

Recruiting

Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Breast Cancer

Japan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Active, not recruiting

Research on the Development and Validation of Personalized Exercise Prescriptions for Breast Cancer Patients Based on Large Language Models

Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Completed

Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer

Breast Cancer

China
Region Skane

Enrolling by invitation

ExBRAC- Expressive Writing in Breast Cancer (ExBRAC)

Breast Cancer

Sweden
Anhui Provincial Cancer Hospital

Completed

Super-Resolution Ultrasound Microvascular Mapping for Non-Invasive Breast Cancer Molecular Subtyping: A Validated Nomogram (SRUS-Map)

Breast Cancer

China
M.D. Anderson Cancer Center

Suspended

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

Breast Cancer

United States
Rabin Medical Center
SPARK Israel; ICRF, United States; IMH, Israel; IMS, Israel; ISF, Israel; Tel Aviv...

Completed

Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery

Breast Cancer

Israel
Beni-Suef University

Completed

Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt (Clinical and P)

Breast Cancer

Egypt
G. d'Annunzio University

Completed

Development and Assessment of the 8-item Chronic Pain Acceptance Questionnaire to Measure Disease Acceptance in Women With Breast Cancer (CPAQ-8-BC)

Breast Cancer

Italy
University of British Columbia

Enrolling by invitation

Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest (VascuLens RCT)

Breast Cancer

Canada
Florence Nightingale Hospital, Istanbul

Completed

Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.

Breast Cancer
Shaukat Khanum Memorial Cancer Hospital & Research...

Completed

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Breast Cancer

Pakistan
Beijing HuiLongGuan Hospital

Active, not recruiting

Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention

Breast Cancer

China
St. Antonius Hospital

Active, not recruiting

Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients (INFLUENCE II)

Breast Cancer

Netherlands, Italy
Tri-Service General Hospital

Completed

Study of Effects of Dao-yin Exercise on the Patients With Breast Cancer Post Operation and Receiving Adjuvant Chemotherapy

Breast Cancer

Taiwan
Arafarma Group, S.A.

Completed

Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors. (DOLFLEX)

Breast Cancer

Spain
Tensive SRL

Completed

REGENERA Implant in Excised Non-Malignant Breast Lesions

Benign Breast Disease

Italy
National Cancer Institute (NCI)

Completed

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Invasive Breast Carcinoma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital; Spaulding Rehabilitation Hospital

Completed

Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors

Breast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast Cancer

United States
German Cancer Research Center

Completed

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Inflammation | Breast Cancer | Lifestyle | Hormone Therapy | Breast Cancer Mortality | Inflammatory Biomarkers | Breast Cancer Survival | Postmenopausal Breast Cancer | Genetic Factors | Phytoestrogens
Marengo Therapeutics, Inc.

Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors (START-002)

HR+, HER2-, Advanced Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast Cancer

United States, Canada
University of Chicago

Recruiting

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Breast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Nigeria
Samsung Medical Center

Recruiting

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Triple Negative Breast Cancer | Pembrolizumab | Neoadjuvant Chemotherapy | Tumor Microenvironment

Korea, Republic of
Biocon Biologics UK Ltd

Terminated

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients

India
Danish Breast Cancer Cooperative Group

Withdrawn

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer (DISCORDANT)

Metastatic Breast Cancer | ER-positive Breast Cancer | Luminal B | Her2 Enriched | Basal Like
Memorial Sloan Kettering Cancer Center

Completed

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Breast Cancer

United States
Sultan Qaboos Comprehensive Cancer Center

Completed

The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Oman
Istituti Clinici Scientifici Maugeri SpA

Completed

Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer (BLITE-01)

Breast Cancer | Radiotherapy Side Effect | Breast Implant; Complications | Breast Implant Protrusion

Italy
Kyoto Breast Cancer Research Network
Pfizer

Completed

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

Taiwan, Japan, Korea, Republic of, Australia, Hong Kong

‹
1
2
...
65
66
67
68
69
70
71
...
199
200
›

Subscribe